Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of metformin and cimetidine on Lonsurf pharmacokinetics in metastatic colorectal cancer
2019-000276-41Phase 4Completed
- Sponsor
- Erasmus MC
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of trifluridine + tipiracil, metformin and cimetidine in metastatic colorectal adenocarcinoma (mCRC), sponsored by Erasmus MC. Started Mar 2020; status: completed.
02
Drugs
trifluridine + tipiracilmetformincimetidine
03
Conditions
metastatic colorectal adenocarcinoma (mCRC)
Beyond the preview
Go deeper on 2019-000276-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-000276-41.